<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <title>Considerations </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">
</head>

<body>

<div class="uk-container">
    <div>
        <div class="chapter-header">
            <div class="header-title">
                <div>
                    <img src="ic_chapter.svg" width="16" height="16" class="ic_chapter_icon">
                </div>
                <p class="chapter-title">IV. Laboratory Diagnosis of Active Tuberculosis</p>
            </div>
            <p class="last-updated"><i>Last Updated October 2025</i></p>
        </div>
        <hr>
    </div>
        <p class="uk-paragraph">
        Active TB disease diagnosis is usually pursued by mycobacterial acid -fast bacilli smear (“AFB smear”), mycobacterial culture (“AFB culture”), nucleic acid amplification tests (e.g., Xpert MTB/RIF), radiological exam, and histopathology.        </p>

        <img src="../assets/considerations_image_1.png">

        <p class="uk-paragraph">
        Phenotypic drug-susceptibility testing (DST) is optimal for patient care and genotyping is paramount for tuberculosis prevention and control. Both DST and genotyping require recovery of an M. tuberculosis isolate from a positive culture. Thus, adequate samples for mycobacterial culture should be obtained whenever possible.        </p>

        <p class="uk-paragraph">
            Diagnostic samples can be collected after TB treatment initiation among patients with life-threatening disease or other compelling indications for immediate TB treatment (Figure 1).
        </p>

        <p class="uk-paragraph">
            TST and/or IGRA are negative in 10-30% of patients with active TB. <b>Thus, a negative TST and/or IGRA do not rule out active TB.</b>
        </p>
        <p class="uk-paragraph">
            The sensitivity of each test (smear, culture, and nucleic acid amplification) differs by sample source (e.g., sputum vs. cerebrospinal fluid).
        </p>
        <p class="uk-paragraph">
            ATS/CDC/IDSA guidelines for Diagnosis of Tuberculosis in Adults and Children are a comprehensive source for laboratory tests for TB diagnosis [Lewinsohn et al. Clinical Infectious Diseases, 2017].
        </p>
</div>
</body>

<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
</html>
